WASHINGTON, Sept 12 (Reuters) - Generic drug companies candevelop generic versions of Lovaza, a fish-oil derived drug usedto treat high cholesterol, a U.S. appeals court ruled onThursday. In April ...
In a ruling issued on Thursday, the U.S. Court of Appeals for the Federal Circuit invalidated one of BASF SE’s patents on the heart drug Lovaza. The ruling, which reverses a lower court judge, clears ...
Law360 (March 30, 2011, 5:28 PM EDT) -- Apotex Corp. on Tuesday agreed to hold off on manufacturing a generic version of Lovaza until 2015 to resolve Norwegian pharmaceutical company Pronova BioPharma ...
LONDON, May 30 (Reuters) - Norway's Pronova BioPharma, which supplies the omega-3 heart medicine Lovaza to GlaxoSmithKline, has defeated a U.S. patent challenge from two generics companies, sending ...
LAVAL, Quebec, Sept. 22, 2010 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX-V:NTB) subsidiary Acasti Pharma Inc. reports preclinical results showing that ...
New Delhi, Sep 20 (PTI) Drug firm Strides Shasun today said it has received approval from the United States health regulator for generic Omega-3-acid ethyl esters softgel capsules used for reducing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results